CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 110 entries

View as:

Skin Tape Transcriptome Methods in Children

Phase: N/A Priority: Normal

NCT ID: NCT04180644 Org: User:

Start: 01/10/20 End: 02/05/20 Due: 02/05/21

Macrophage Programing in Acute Lung Injury

Phase: N/A Priority: Normal

NCT ID: NCT03844893 Org: User:

Start: 10/31/19 End: 03/31/23 Due: 03/31/24

Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction Study

Phase: N/A Priority: Normal

NCT ID: NCT04942548 Org: User:

Start: 07/25/19 End: 07/24/23 Due: 07/24/24

Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal

NCT ID: NCT03746197 Org: User:

Start: 06/06/18 End: 07/01/20 Due: 07/01/21

The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

Phase: N/A Priority: Normal

NCT ID: NCT02831894 Org: User:

Start: 11/02/15 End: 06/30/19 Due: 06/30/20

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

Phase: N/A Priority: Normal

NCT ID: NCT04844359 Org: User:

Start: 01/06/21 End: 07/31/25 Due: 07/31/26

Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs

Phase: N/A Priority: Normal

NCT ID: NCT04353752 Org: User:

Start: 09/16/19 End: 12/31/25 Due: 12/31/26

Skin Barrier Assessment in Pregnancy and at Birth

Phase: N/A Priority: Normal

NCT ID: NCT04445298 Org: User:

Start: 08/03/20 End: 07/01/22 Due: 07/01/23

: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)

Phase: N/A Priority: Normal

NCT ID: NCT03445793 Org: User:

Start: 03/01/18 End: 11/01/19 Due: 11/01/20

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

Phase: N/A Priority: Normal

NCT ID: NCT04283539 Org: User:

Start: 06/01/20 End: 02/28/25 Due: 02/28/26

Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea

Phase: N/A Priority: Normal

NCT ID: NCT00238069 Org: User:

Start: 12/31/04 End: 08/31/05 Due: 08/31/06

Skin Barrier Abnormalities and Oxidative Stress Response

Phase: N/A Priority: Normal

NCT ID: NCT04606615 Org: User:

Start: 10/16/20 End: 12/31/22 Due: 12/31/23

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Phase: N/A Priority: Normal

NCT ID: NCT00557180 Org: User:

Start: 10/31/07 End: 02/28/11 Due: 02/28/12

Effect of Omalizumab in the Skin of Food Allergy Patients

Phase: N/A Priority: Normal

NCT ID: NCT06618963 Org: User:

Start: 10/01/24 End: 12/31/26 Due: 12/31/27

Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT01491646 Org: User:

Start: 11/30/10 End: 10/31/13 Due: 10/31/14

Skin Characteristics of Parents of Food Allergic Pediatric Patients

Phase: N/A Priority: Normal

NCT ID: NCT04198753 Org: User:

Start: 01/23/20 End: 10/06/20 Due: 10/06/21

Use of Blinded Tapering for Hypnotic Discontinuation

Phase: N/A Priority: Normal

NCT ID: NCT04050176 Org: User:

Start: 12/16/19 End: 06/30/26 Due: 06/30/27

Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device

Phase: N/A Priority: Normal

NCT ID: NCT01234077 Org: User:

Start: 03/31/10 End: 09/30/10 Due: 09/30/11

Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis

Phase: N/A Priority: Normal

NCT ID: NCT00560989 Org: User:

Start: 03/31/07 End: 03/31/07 Due: 03/31/08

The Role of Bacterial Toxins in Human Skin Disease

Phase: N/A Priority: Normal

NCT ID: NCT02910791 Org: User:

Start: 02/20/19 End: 12/31/23 Due: 12/31/24

Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)

Phase: N/A Priority: Normal

NCT ID: NCT00623246 Org: User:

Start: 12/31/07 End: 11/30/15 Due: 11/30/16

Use of DNAse in Neutrophilic Asthma

Phase: N/A Priority: Normal

NCT ID: NCT03994380 Org: User:

Start: 02/12/20 End: 12/31/20 Due: 12/31/21

Interstitial Lung Disease in Early Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT03977415 Org: User:

Start: 03/27/18 End: 08/01/21 Due: 08/01/22

Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Phase: N/A Priority: Normal

NCT ID: NCT01700257 Org: User:

Start: 05/31/12 End: 12/07/20 Due: 12/07/21

The Breathe Well Program for Adults With Asthma

Phase: N/A Priority: Normal

NCT ID: NCT02761837 Org: User:

Start: 10/31/16 End: 06/30/23 Due: 06/30/24

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Skin Tape Transcriptome Methods in Children	NCT04180644	National Jewish Health	user2@example.com	None	2020-01-10	2020-02-05	2021-02-05	-	-	2025-07-14
Macrophage Programing in Acute Lung Injury	NCT03844893	National Jewish Health	user2@example.com	None	2019-10-31	2023-03-31	2024-03-31	-	-	2025-07-14
Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction Study	NCT04942548	National Jewish Health	user2@example.com	None	2019-07-25	2023-07-24	2024-07-24	-	-	2025-07-14
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus	NCT03746197	National Jewish Health	user2@example.com	None	2018-06-06	2020-07-01	2021-07-01	-	-	2025-07-14
The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation	NCT02831894	National Jewish Health	user2@example.com	None	2015-11-02	2019-06-30	2020-06-30	-	-	2025-07-14
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis	NCT04844359	National Jewish Health	user2@example.com	None	2021-01-06	2025-07-31	2026-07-31	-	-	2025-07-14
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs	NCT04353752	National Jewish Health	user2@example.com	None	2019-09-16	2025-12-31	2026-12-31	-	-	2025-07-14
Skin Barrier Assessment in Pregnancy and at Birth	NCT04445298	National Jewish Health	user2@example.com	None	2020-08-03	2022-07-01	2023-07-01	-	-	2025-07-14
: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)	NCT03445793	National Jewish Health	user2@example.com	None	2018-03-01	2019-11-01	2020-11-01	-	-	2025-07-14
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy	NCT04283539	National Jewish Health	user2@example.com	None	2020-06-01	2025-02-28	2026-02-28	-	-	2025-07-14
Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea	NCT00238069	National Jewish Health	user2@example.com	None	2004-12-31	2005-08-31	2006-08-31	-	-	2025-07-14
Skin Barrier Abnormalities and Oxidative Stress Response	NCT04606615	National Jewish Health	user2@example.com	None	2020-10-16	2022-12-31	2023-12-31	-	-	2025-07-14
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications	NCT00557180	National Jewish Health	user2@example.com	None	2007-10-31	2011-02-28	2012-02-28	-	-	2025-07-14
Effect of Omalizumab in the Skin of Food Allergy Patients	NCT06618963	National Jewish Health	user2@example.com	None	2024-10-01	2026-12-31	2027-12-31	-	-	2025-07-14
Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension	NCT01491646	National Jewish Health	user2@example.com	None	2010-11-30	2013-10-31	2014-10-31	-	-	2025-07-14
Skin Characteristics of Parents of Food Allergic Pediatric Patients	NCT04198753	National Jewish Health	user2@example.com	None	2020-01-23	2020-10-06	2021-10-06	-	-	2025-07-14
Use of Blinded Tapering for Hypnotic Discontinuation	NCT04050176	National Jewish Health	user2@example.com	None	2019-12-16	2026-06-30	2027-06-30	-	-	2025-07-14
Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device	NCT01234077	National Jewish Health	user2@example.com	None	2010-03-31	2010-09-30	2011-09-30	-	-	2025-07-14
Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis	NCT00560989	National Jewish Health	user2@example.com	None	2007-03-31	2007-03-31	2008-03-31	-	-	2025-07-14
The Role of Bacterial Toxins in Human Skin Disease	NCT02910791	National Jewish Health	user2@example.com	None	2019-02-20	2023-12-31	2024-12-31	-	-	2025-07-14
Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)	NCT00623246	National Jewish Health	user2@example.com	None	2007-12-31	2015-11-30	2016-11-30	-	-	2025-07-14
Use of DNAse in Neutrophilic Asthma	NCT03994380	National Jewish Health	user2@example.com	None	2020-02-12	2020-12-31	2021-12-31	-	-	2025-07-14
Interstitial Lung Disease in Early Rheumatoid Arthritis	NCT03977415	National Jewish Health	user2@example.com	None	2018-03-27	2021-08-01	2022-08-01	-	-	2025-07-14
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker	NCT01700257	National Jewish Health	user2@example.com	None	2012-05-31	2020-12-07	2021-12-07	-	-	2025-07-14
The Breathe Well Program for Adults With Asthma	NCT02761837	National Jewish Health	user2@example.com	None	2016-10-31	2023-06-30	2024-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance